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The Mission: To urge all relevant entities within the
international cardiac surgery, industry, and government
sectors to commit to develop and implement an eﬀective
strategy to address the scourge of rheumatic heart dis-
ease in the developing world through increased access to
life-saving cardiac surgery.
Twelve years after cardiologists and cardiac surgeons
from all over the world issued the ‘‘Drakensberg
Declaration on the Control of Rheumatic Fever and
Rheumatic Heart Disease in Africa,’’ calling on the
world community to address the prevention and treat-
ment of rheumatic heart disease (RHD) through improv-
ing living conditions, to develop pilot programs at
selected sites for control of rheumatic fever and rheum-
atic heart disease, and to periodically review progress
made and challenges that remain [1], RHD still accounts
for a major proportion of cardiovascular diseases in
children and young adults in low- and middle-income
countries, where more than 80% of the world popula-
tion live. Globally equal in prevalence to human
immunodeﬁciency virus infection, RHD aﬀects 33 mil-
lion people worldwide [2].
Prevention eﬀorts have been important but have
failed to eradicate the disease. At the present time,
the only eﬀective treatment for symptomatic RHD is
open heart surgery, yet that life-saving cardiac surgery
is woefully absent in many endemic regions. In this
declaration, we propose a framework structure to
create a coordinated and transparent international alli-
ance to address this inequality.
Elimination of RHD and relief from its debilitating
consequences can only occur through interdisciplinary
eﬀort, as outlined in the Cairo Accord [3]. Previous
initiatives have focused on primary and secondary pre-
vention of RHD [4]. Their declarations have been
recognized by the Heads of State of African Union
countries and by the World Health Organization.
This recognition has been important in developing rec-
ommendations by the World Health Organization
Executive Board to the 2018 World Health Assembly
to enlist global commitment to RHD.
Progress in prevention of RHD has been slow dur-
ing the past 15 years [5], and thus, surgery will likely
remain an integral part of RHD treatment for several
generations. Lack of access to cardiac surgery services
and the cost of valve replacement render this dis-
ease fatal for millions of patients. In endemic regions
of low-income countries, the need for cardiac surgery is
estimated at 300 operations per 1 million population
(‘‘Global Unmet Needs in Cardiac Surgery,’’
Asian Cardiovascular & Thoracic Annals
2018, Vol. 26(7) 535–539
 The Author(s) 2018
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/0218492318791359
journals.sagepub.com/home/aan
1Christiaan Barnard Division of Cardiothoracic Surgery, Faculty of Health
Sciences, University of Cape Town, Cape Town, South Africa
2Division of Cardiothoracic Surgery, University of Vermont, Burlington,
Vermont
3Chain of Hope, Chelsea, London, United Kingdom
4Department of Cardiovascular Surgery, Universita¨ts-Herzzentrum
Freiburg–Bad Krotzingen, Freiburg, Germany
5Hatter Institute of Cardiovascular Research in Africa, Faculty of Health
Sciences, University of Cape Town, Cape Town, South Africa
6Division of Pediatric Cardiology, Department of Pediatrics and Child
Health, University of Cape Town, Cape Town, South Africa
7Department of Surgery, Johns Hopkins Medicine, Baltimore, Maryland
8Faculty of Health Sciences, University of Cape Town, Cape Town, South
Africa
9Hoˆpital Europe´en Georges Pompidou, Paris, France
10Wake Forest Institute of Regenerative Medicine, Wake Forest School of
Medicine, Winston-Salem, North Carolina
Corresponding author:
Peter Zilla, University of Cape Town/Groote Schuur Hospital, Chris
Barnard Division of Cardiothoracic Surgery, Chris Barnard Building, 3rd
Flr, 3 Anzio Rd Observatory, Cape Town, South Africa.
Email: peter.zilla@uct.ac.zal
This article is copublished in The Annals of Thoracic Surgery, Asian
Cardiovascular and Thoracic Annals, Cardiovascular Journal of Africa, Chinese
Circulation Journal, European Journal of Cardio-Thoracic Surgery, The Journal of
Thoracic and Cardiovascular Surgery, Polish Journal of Thoracic and
Cardiovascular Surgery, South African Heart Journal, and South African
Medical Journal.
unpublished work by Zilla and colleagues), yet, the
nearly 1 billion people living in Sub-Saharan Africa
between the Maghreb and South Africa have access to
only 22 cardiac centers [6]. Although there is 1 cardiac
center per 120,000 people in the United States, there is
only 1 center per 33 million in Africa. Furthermore,
RHD is not restricted to Sub-Saharan Africa. India,
Pakistan, China, and Indonesia together account for
72% of mortality of RHD cases worldwide [2].
We strongly endorse the position that building
local capacity is the best solution for this serious
public health problem. Many lives have been saved by
humanitarian ‘‘ﬂy-in’’ missions, but these eﬀorts are
neither sustainable nor cost-eﬀective. The nongovern-
ment organizations associated with these programs are
shifting focus toward building long-term partnerships
with host countries to develop autonomous local ser-
vices with government buy-in [7]. A massive investment
in new cardiac centers in these regions is unrealistic;
globally, an additional few thousand cardiac centers
would be required to address the unmet needs
(‘‘Global Unmet Needs in Cardiac Surgery,’’ unpub-
lished work by Zilla and colleagues).
It is not suﬃcient for governments and
nongovernment organizations to support the training
of cardiologists and cardiac surgeons from these
regions at high-income country facilities, because they
will not be trained in most of the pathologies awaiting
them in their own countries and will be unfamiliar with
resource-constrained circumstances.
There is an urgent need for a concerted eﬀort by
all stakeholders to address the plight of the poor in
these regions who need cardiac surgery. As signatories
and endorsing organizations of the Cape Town
Declaration, we propose a comprehensive solution
with two principal aims.
Aim 1: To establish an international working group
(coalition) of individuals from cardiac surgery societies
and representatives from industry, cardiology, and gov-
ernment to evaluate and endorse the development of car-
diac care in low- to middle-income countries.
It is proposed that the international coalition will
have 2 representatives from each of the major cardiac
surgery societies (The Society of Thoracic Surgeons,
American Association for Thoracic Surgery, European
Association for Cardio-Thoracic Surgery, The Asian
Society for Cardiovascular and Thoracic Surgery), and
ideally, 2 additional committed members. There will be
at least 1 representative from industry and at least 1
appointee to represent cardiology/the World Heart
Federation. The responsibilities of the Coalition will
include establishing criteria for centers for clinical
care and training as well as selecting and endorsing
the centers. The Coalition will derive metrics of quality
and performance for the endorsed centers of training
and clinical care and will encourage standardization of
care to the extent possible.
The Coalition will advocate mutually agreed policies
and prescriptions to relevant governmental bodies. In
addition, the Coalition will engage industry and private
sources of philanthropy for ﬁnancial assistance with
large-scale initiatives.
Aim 2: To advocate for the training of cardiac
surgeons and other key specialized caregivers at identi-
ﬁed and endorsed centers in low- to middle-income
countries.
The case has been made above for critical providers
obtaining training in settings and conditions and dealing
with the cardiac pathologies that they will be encounter-
ing in their practice in their countries of origin.
It is preferred that centers endorsed by this Coalition
be based on an alliance of four stakeholders: a program
initiator (eg, a government, a university, or a nongo-
vernment organization), an audited training center in a
low- to middle-income country, a committed partner
institution in a high-income country, and a consortium
of industry that would sign on as benefactors to the
speciﬁc program. Because regional centers in low- to
middle-income countries typically operate within a
resource-scarce environment, resulting in lower case
numbers than needed for the training of outside resi-
dents, a facilitated capacity increase to help achieve
higher case numbers would beneﬁt all participants.
Summary: It is imperative that action be taken
urgently. A nucleus of 1 to 3 centers should be identiﬁed
and endorsed, with coordination by global stakeholders,
as quickly as possible. The implementation of this
initiative will only be made possible by the endorsement
of all the relevant cardiothoracic societies and agencies
subscribing to clearly deﬁned targets and timelines,
and committing appropriate resources. The time to
act is now.
Signatories
For Cardiothoracic Societies (in alphabetical order)
Bongani Mayosi (Past-President, Pan-African Society
of Cardiology [PASCAR], South Africa)
Charles Yankah (President, Pan-African Society for
Cardiothoracic Surgery [PASCaTS], Ghana/
Germany)
David Wood (President, World Heart Federation
[WHF], United Kingdom)
Friedhelm Beyersdorf (Editor in Chief, European
Journal of Cardio-Thoracic Surgery, Germany)
James Kirklin (Representative, American Association
for Thoracic Surgery [AATS], USA)
Jose Pomar (Past President, European Association for
Cardio-Thoracic Surgery [EACTS], Spain)
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Joseph Bavaria (Past-President, The Society of
Thoracic Surgeons [STS], USA)
Juan Mejia (Representative, Brazilian Society of
Cardiovascular Surgery, Brazil)
Karen Sliwa (President-Elect, World Heart Federation
[WHF], South Africa)
Kumud Dhital (Representative, Australian & New
Zealand Society of Cardiac and Thoracic Surgeons
[ANZSCTS], Australia)
Liesl Zu¨hlke (President, South African Heart
Association, South Africa)
R Morton Bolman, III (Representative, American
Association for Thoracic Surgery [AATS], USA)
Robert Kleinloog (President, Society of Cardiothoracic
Surgeons of South Africa [SCTSSA], South Africa)
Robert S.D. Higgins (President Elect, The Society of
Thoracic Surgeons [STS], USA)
Shinichi Takamoto (President, Asian Society for
Cardiovascular and Thoracic Surgery [ASCVTS],
Japan)
Wei Wang (Representative, Chinese Society for
Thoracic and Cardiovascular Surgery, China)
Humanitarian and Government Organizations
(in alphabetical order)
Afksendiyos Kalangos (President: Kalangos
Foundation, Greece)
Alain Carpentier (Alain Carpentier Foundation, France)
Magdi Yacoub (President, Chain of Hope, United
Kingdom/Egypt)
Nicole Sekarski (Le Petit Coeur, Switzerland)
Rene´ Preˆtre (Le Petit Coeur, Switzerland)
Richard Kamwi (Past Minister of Health, Namibia)
Sylvain Chauvaud (La Chaıˆne de l’Espoir, France)
Industry and Health Economy Representatives
(in alphabetical order)
Alistair Simpson (General Manager Cardiac Surgery,
LivaNova, United Kingdom)
Barry Wilson (Former President, Medtronic
International)
Devi Prassad Shetty (NH Group, India)
Francois Bonnici (Director, Bertha Centre for Social
Innovation and Entrepreneurship, South Africa)
Helmut Straubinger (Ex Chief Executive Oﬃcer, Jena
Valve; Chief Executive Oﬃcer, Tricares, Germany)
Iraj Abedian (Pan-African Capital Holding, South
Africa)
Jacques Kpodonu (Author, Global Health
Innovations, USA/Ghana)
Kathryn Gleason (Co-Founder, TeamFund Inc)
Lee Chuen Neng (Biomedical Institute for Global
Health Research & Technology, Singapore)
Lenias Hwenda (Chief Executive Oﬃcer, Medicines for
Africa, Zimbabwe/Switzerland)
Markus Stirner-Schilling (VP Marketing & Academy,
Europe, Middle East & Africa, Getinge, Germany)
Michael P. Phalen (Executive President, MedSurg
Boston Scientiﬁc, USA)
Patrice Matchaba (Global Head Corporate
Responsibility, Novartis, Switzerland)
Raenette Taljaard (‘‘Economic Research of South
Africa’’ [ERSA], South Africa)
Salah Malek (President, Middle East and Africa,
Getinge, United Arab Emirates)
Samukeliso Dube (Chief Medical Oﬃcer, Royal
Philips, Netherlands)
Sidhant Jena (Chief Executive Oﬃcer, Jana Care, USA)
Tim Ring (Chairman and Chief Executive Oﬃcer, C.R.
Bard Inc, USA)
For Major Journals and Publications (in alphabetical
order)
Dan Ncayiyana (Past Editor in Chief, South African
Medical Journal, South Africa)
David Williams (Past Editor in Chief, Biomaterials,
USA)
Friedhelm Beyersdorf (Editor in Chief, European
Journal of Cardio-Thoracic Surgery, Germany)
G Alexander Patterson (Editor in Chief, The Annals of
Thoracic Surgery, USA)
JP van Niekerk (Past Editor in Chief, South African
Medical Journal, South Africa)
Marko Turina (Past Editor in Chief, European Journal
of Cardio-Thoracic Surgery; Past Editor in Chief,
Cardiothoracic Surgery Network [CTSNet] and
Multimedia Manual of Cardio-Thoracic Surgery,
Switzerland)
Sampath Kumar (Editor in Chief, Asian Cardiovascular
and Thoracic Annals, India)
Other Signatory Delegates to the Cape Town
Dialogue (in alphabetical order)
Abdelmalek Bouzid (Algeria)
Agneta Simionescu (USA)
Allan Glanville (Australia)
Ana Olga Mocumbi (Mozambique)
Andrea Griesmacher (Austria)
Andreas Zuckermann (Austria)
Beath Walpoth (Switzerland)
Bernard Gersh (USA)
Bojan Biocina (Croatia)
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Bruno Podesser (Austria)
Bruno Reichart (Germany)
Carlijn Bouten (Netherlands)
Christian Hagl (Germany)
Claudia Goettsch (Germany)
Craig Goergen (USA)
Cynthia St. Hilaire (USA)
Dan Simionescu (USA)
Darshan Reddy (South Africa)
David Cooper (USA)
David Vorp (USA)
Devagourou Velayodamu (India)
Eduardo Becerra (Chile)
Elena Aikawa (USA)
Elmi Muller (South Africa)
Francis Smit (South Africa)
Frederick C de Beer (USA)
Gennadiy Khubulava (Russia)
Georg Lutter (Germany)
Georg Wieselthaler (USA)
Gino Gerosa (Italy)
Giovanni Ferrari (USA)
Giuseppe Faggian (Italy)
Glen Gaudette (USA)
Guenther Laufer (Austria)
Hector Sanchez (Argentina)
Hendrik Treede (Germany)
Henning Rud Andersen (Denmark)
Hermann Reichenspurner (Germany)
Howard Eisen (USA)
Ivan Netuka (Czech Republic)
Jacques Scherman (South Africa)
Jim Schurman (USA)
Jo Meinhart (Austria)
Johan Brink (South Africa)
John Curci (USA)
Joshua Hutcheson (USA)
Justiaan Swanevelder (South Africa)
Luke Brewster (USA)
Manuel Antunes (Portugal)
Manfred Deutsch (Austria)
Martin Grabenwoeger (Austria)
Masanori Aikawa (USA)
Mathias Mueller (Austria)
Max Emmert (Switzerland)
Mervyn Gotsman (Israel)
Michael Knaut (Germany)
Mike Wolf (USA)
Minoru Ono (Japan)
Mpiko Ntsekhe (South Africa)
Nicolas l’Heureux (France)
Nir Uriel (USA)
Norberto de Vega (Spain)
Olga Plattner (Austria)
Otmar Pachinger (Austria)
Patrick Commerford (South Africa)
Paul Mohacsi (Switzerland)
Rainald Seitelberger (Austria)
Richard Bianco (USA)
Richard Daly (USA)
Robin Kleinloog (South Africa)
Robert Frater (USA)
Saeid Hosseini (Iran)
Simon Hoerstrup (Switzerland)
Simon Maltais (USA)
Simon Matskeplishvili (Russia)
Solomon Benatar (South Africa/Canada)
Stephan Schueller (United Kingdom)
Susan Vosloo (South Africa)
Taweesak Chotivatanapong (Thailand)
Ted Feldman (USA)
Teddy Fischlein (Germany)
Theodoros Koﬁdis (Singapore)
Timothy Pennel (South Africa)
Toshi Shinoka (USA)
Ulf Hedin (Sweden)
Ulrich Steinseifer (Germany)
Volkmar Falk (Germany)
Walter Klepetko (Austria)
Willie Koen (South Africa)
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